Pica Eating Disorder Treatment Market Overview

Pica is an eating disorder in which people eat nonnutritive substances which are not typically thought of as food such as paper, cloth, soap, hair, wool, soil, chalk, string, talcum powder, gum, paint, metal, pebbles, charcoal, ash, clay, starch, or ice.  The global Pica Eating Disorder Treatment market is projected to witness significant growth in the forecast period. Pica eating disorder often occurs with mental health disorders that are associated with impaired functioning and can be seen in pregnant women. Thus, the number of pregnancies increasing in the world is the major driving factor of the pica eating disorder treatment market. Pregnant women have cravings for different foods and should ask for an iron test from their doctor and it can be corrected by taking iron supplements.

Moreover, growing cases of depression and panic disorders across the world are key factors to boost the growth of the pica eating disorder treatment market. According to the Centre for Disease Control and Prevention, 1 in 6 children aged 2 to 8 has been diagnosed with a mental, behavioral, or developmental disorder in the United States.

Furthermore, iron deficiency anemia and malnutrition are the most common cause of pica. Pica eating disorder can be associated with intellectual disability, excoriation disorder (skin picking), and trichotillomania (hair-pulling disorder). Hence, rising incidences of such disorders are expected to enlarge the growth of the global Pica Eating Disorder Treatment market.

Covid-19 Impact on Pica Eating Disorder Treatment Market:

In addition, the current Pica Eating Disorder Treatment Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Pica Eating Disorder Treatment Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Pica Eating Disorder Treatment Market Segment Overview

Pica eating disorders can occur in any age group. There is no such kind of laboratory tests for pica instead the diagnosis can be done clinically. There are various pica eating disorder treatment options available by using dietary supplements, different therapies are also available like psychotic therapy, cognitive-behavioral approaches, nutritional counseling, etc. Pica can have causes that are not because of underlying diseases but because of stress, cultural factors, nutritional deficiencies, and pregnancy. Nutritional deficiencies can be managed by taking dietary supplements. Also, mental illness can be treated by taking psychotic therapy. 

Pica Eating Disorder Treatment Market, By Drug Type

·       Dietary Supplements
·       Antipsychotic Drugs
·       Antidepressants
·       Mood Stabilizers

Pica Eating Disorder Treatment Market, By Route of Administration

·       Oral
·       Injectable

Pica Eating Disorder Treatment Market, By End User

·       Hospital Pharmacies
·       Retail Pharmacies
·       Drug Stores
·       Mail Order Pharmacies

Pica Eating Disorder Treatment Regional Overview

In terms of region, North America is at the forefront and is predicted to continue to retain its lead position through the forecast period. Pica eating disorder is commonly seen in children with autism spectrum disorder (ASD). According to the Centre for Disease Control and Prevention, the prevalence of pica eating disorder was around 28% in children with both ASD and co-occurring ID in the United States. Hence, higher prevalence demands novel pica eating disorder treatment in the region. Similarly, the Asia Pacific region is expected to have a major share of the Pica Eating Disorder Treatment market. This is because of the rising prevalence of pica mostly in developing countries. Japan has the highest rate of prevalence, which in turn high demand for Pica Eating Disorder Treatment. It eventually boosts the growth of the market in this region.

Pica Eating Disorder Treatment Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Pica Eating Disorder Treatment Market, Key Players

·       Novartis International AG
·       GlaxoSmithKline plc.
·       Merck KGaA
·       Sun Pharmaceutical Industries Limited
·       Glenmark Pharmaceutical
·       Torrent Pharmaceuticals Ltd.
·       Micro Labs Limited
·       FDC Limited
·       Emcure Pharmaceuticals
·       Mankind Pharma